PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Market Analysis and Trades for 2/13

PharmD_KS's avatar
PharmD_KS
Feb 12, 2026
∙ Paid

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so the Discord option includes Substack content but a new Substack subscription does not include Discord access.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

The 2026 Equity Markets Year Ahead can be watched here: 2026 Equity Markets Year Ahead

The weekly post for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. It can be found here Market Analysis for the Week of 2/8

Wild day today as NQ and ES floated up to range high all night which had me skeptical. Being long into range high is almost never correct. I was skeptical of this range breaking ahead of CPI. That looked very right at open, and then the wave of selling after the IB made it very wrong as we broke range to the downside. Pretty crazy after testing range high overnight.

On a cash hours basis the day trade short setup triggered a weekly bearish scenario and the rest was history:

369-388 was rejected at open, the IB low was set at 25169-25179 (169.75)

On a weekly basis a rejection up there which then triggered a loss of 25169-25179 would have sellers back in firm control. The move was violent after 169-179 was lost

Today saw a spike down into the close (see the starter kit). We have a b-shaped profile from today quite a bit below established value for the week. Here’s how we’ll play it:

Paid Content Below or in the Discord

JOIN THE DISCORD

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 PharmD_KS · Market data by Intrinio · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture